Comments

BioAtla Stock Price, Quotes and Forecasts

Q: What sector and industry does BioAtla (BCAB) operate in?

BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BCABNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

BioAtla (BCAB) Forecast

News Earnings BioAtla (BCAB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

BioAtla Stock Price, Quotes and Forecasts | NASDAQ:BCAB | Benzinga

Explore BioAtla stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCAB.

Open	$0.28
Close	-
Volume / Avg.	151.76K / 805.72K
Day Range	$0.26 - $0.28
52 Wk Range	0.24 - 3.97
Market Cap	$15.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	7.92%
Days to Cover	5.4

Recent News

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months

Michael Burry, the investor renowned for his prescient bet against the housing market before the 2008 financial crisis, has seen his recent wager on Chinese stocks pay significant dividends.

Kaustubh Bagalkote

'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio

Famed investor Michael Burry, known for his prescient bet against the housing market before the 2008 financial crisis, has made significant changes to his hedge fund's portfolio in the second quarter of 2024.

Kaustubh Bagalkote

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.28
Close	-
Volume / Avg.	151.76K / 805.72K
Day Range	$0.26 - $0.28
52 Wk Range	0.24 - 3.97
Market Cap	$15.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	7.92%
Days to Cover	5.4

About BioAtla Inc

Sector

Health Care

Industry

Biotechnology

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development...

Got Questions? Ask

Analyze BCAB's financials

How is BCAB's EBITDA trending?

How is BCAB's revenue growing?

What are BCAB's Bollinger Band values?

What is BCAB's debt-to-equity ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioAtla (BCAB) stock?

You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.

View our list of the best stock brokerages

Who are BioAtla (BCAB) competitors?

Other companies in BioAtla’s space includes: Curis (NASDAQ:CRIS), Nanoviricides (AMEX:NNVC), Abpro Hldgs (NASDAQ:ABP), ABVC BioPharma (NASDAQ:ABVC) and Longeveron (NASDAQ:LGVN).

What is the forecast, or price target, for BioAtla (BCAB) stock?

BioAtla has a consensus price target of $12.29.

What is the current price for BioAtla (BCAB)?

The stock price for BioAtla (NASDAQ: BCAB) is $0.2632 last updated April 9, 2025 at 11:23 AM EDT.

Does BioAtla (BCAB) pay a dividend?

There are no upcoming dividends for BioAtla.

When is BioAtla (NASDAQ:BCAB) reporting earnings?

BioAtla’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is BioAtla (BCAB) going to split?

There is no upcoming split for BioAtla.

What sector and industry does BioAtla (BCAB) operate in?

BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.